Antiviral prodrugs, intermediate-and long-acting formulations and methods
AssigneeThe Regents of the University of California
InventorsKarl Y. Hostetler, James Beadle, Nadejda Valiaeva, Robert T. Schooley
Life of this patent
Estimating the term…
Abstract
Compounds and pharmaceutical formulations including a compound and an oil, which may be formulated for intermediate- or long-acting intramuscular injection. Methods for treating respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), coronavirus, SARS CoV-2, and other RNA virus infections in mammals.
Claims8
A compound of the following structure or a pharmaceutically acceptable salt thereof:
A compound of the following structure or a pharmaceutically acceptable salt thereof:
A compound of the following structure or a pharmaceutically acceptable salt thereof:
A compound of the following structure or a pharmaceutically acceptable salt thereof:
A compound of the following structure or a pharmaceutically acceptable salt thereof:
A compound of the following structure or a pharmaceutically acceptable salt thereof:
A compound of following structure or a pharmaceutically acceptable salt thereof:
A compound the following structure or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.